Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness.

J Transl Med · 2019 · PMC6734315 · PMID 31500625

Europe PMC DOI

hedged sentence

0.0770

closest p · 1.5× alpha

0.0770

boldest claim

The sentences

did not reach statistical significancep = 0.077so close (0.05 < p ≤ 0.1)

Of note, there was a trend for higher Fn14 , CXCR2 and CCR3 gene expression levels in semen cell sediment in the high-risk group relative to the low-risk group, but this did not reach statistical significance (p = 0.077, p = 0.089, p = 0.069, respectively) (Fig. 2 c).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.